IGF-1-LR3 (1mg)

High-Stability Analog for Laboratory & Cellular Research

IGF-1-LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic analog of human IGF-1, engineered for enhanced stability and extended biological activity. This 83-amino acid peptide features a structural modification (Long R3) that significantly reduces binding to inhibitory proteins, allowing for a more sustained and potent interaction with the IGF-1 receptor in research models.

Technical Specifications

• Concentration: 1 mg per vial.

• Form: Lyophilized (Freeze-Dried) powder for maximum stability.

• Purity: >98% (HPLC verified).

• Half-Life: Approximately 20–30 hours (3x longer than standard IGF-1).

• Molecular Profile: Analog designed to resist IGFBP (binding protein) interference.

Research Applications

• Cellular Proliferation: Often utilized in studies regarding muscle cell (myoblast) differentiation and satellite cell activation.

• Metabolic Signaling: Useful for exploring insulin-mimetic pathways and glucose transport mechanisms.

• Tissue Regeneration: Applied in research focusing on connective tissue repair and collagen synthesis.

• Longevity Studies: Investigated for its role in cellular aging and IGF-1 receptor sensitivity.

Research Use Only (RUO) & Compliance Notice

Required Disclaimer: This product is intended for laboratory research and in vitro use only. It is not a drug, food, or cosmetic and is not intended for human consumption, diagnostic use, or therapeutic purposes.

FDA Compliance: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Any mention of "benefits" refers exclusively to findings in documented research settings and animal models.

Vendor Notice: By purchasing this product, the buyer acknowledges the risks involved with the handling of this compound. Buyer represents and warrants that through their own independent review and study, they are fully aware and knowledgeable about the product.